Stopping primary prophylaxis is `safe' in patients at high risk of developing Toxoplasma gondii encephalitis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1244, 2000-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Broad-Spectrum Antifungal Prophylaxis in Patients With Cancer at High Risk for Invasive Mold Infections: Counterpoint

By Maertens Johan   Buvé Kristel   Anaissie Elias  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 2, 2008-02 ,pp. : 183-189

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Antibacterial prophylaxis should only be used in high-risk patients undergoing dermatological surgery

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 12, 2010-12 ,pp. : 12-14

Adis International

Access to resources Recommend Favorite

Clinical guidelines for the use of antibacterial prophylaxis among high-risk patients undergoing GI endoscopic procedures have been released.

By  

Inpharma, Vol. 1, Iss. 1416, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Clinical guidelines for the use of antibacterial prophylaxis among high-risk patients undergoing GI endoscopic procedures have been released.

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Broad-Spectrum Antifungal Prophylaxis in Patients With Cancer at High Risk for Invasive Mold Infections: Point

By Gonzalez Antonio V.   Ullmann Andrew J.   Almyroudis Nikolaos G.   Segal Brahm H.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 2, 2008-02 ,pp. : 175-182

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite